Have a feature idea you'd love to see implemented?
Let us know!
DRIO DarioHealth Corp
Price (delayed)
$0.8299
Market cap
$28.3M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.94
Enterprise value
$43.24M
DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software
Highlights
DarioHealth's gross profit has soared by 55% from the previous quarter and by 7% YoY
DRIO's EPS has soared by 54% year-on-year and by 20% since the previous quarter
The revenue rose by 20% since the previous quarter but it has declined by 2.1% year-on-year
The quick ratio has shrunk by 79% YoY and by 33% QoQ
DRIO's equity is down by 14% since the previous quarter and by 14% year-on-year
Key stats
What are the main financial stats of DRIO
Market
Valuations
Earnings
Shares outstanding
34.1M
Market cap
$28.3M
Enterprise value
$43.24M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.43
Price to sales (P/S)
1.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.88
Revenue
$23.05M
EBIT
-$49.34M
EBITDA
-$42.73M
Free cash flow
-$39.37M
Per share
Balance sheet
Liquidity
EPS
-$0.94
Free cash flow per share
-$0.97
Book value per share
$1.95
Revenue per share
$0.57
TBVPS
$0.8
Total assets
$109.95M
Total liabilities
$51.44M
Debt
$30.49M
Equity
$58.51M
Working capital
$10.68M
Debt to equity
0.52
Current ratio
1.57
Quick ratio
1.32
Net debt/EBITDA
-0.35
Margins
Efficiency
Dividend
EBITDA margin
-185.4%
Gross margin
39.9%
Net margin
-205.6%
Operating margin
-261.5%
Return on assets
-38%
Return on equity
-67.3%
Return on invested capital
-158.3%
Return on capital employed
-54.2%
Return on sales
-214.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DRIO stock price
How has the DarioHealth stock price performed over time
Intraday
6.4%
1 week
2.95%
1 month
-14.25%
1 year
-20.2%
YTD
-51.75%
QTD
-25.9%
Financial performance
How have DarioHealth's revenue and profit performed over time
Revenue
$23.05M
Gross profit
$9.2M
Operating income
-$60.29M
Net income
-$47.4M
Gross margin
39.9%
Net margin
-205.6%
DarioHealth's gross profit has soared by 55% from the previous quarter and by 7% YoY
The gross margin has increased by 29% QoQ and by 9% YoY
The net margin has grown by 23% from the previous quarter and by 16% YoY
DRIO's operating margin is up by 22% since the previous quarter but it is down by 21% year-on-year
Growth
What is DarioHealth's growth rate over time
Valuation
What is DarioHealth stock price valuation
P/E
N/A
P/B
0.43
P/S
1.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.88
DRIO's EPS has soared by 54% year-on-year and by 20% since the previous quarter
The P/B is 75% lower than the 5-year quarterly average of 1.7 and 28% lower than the last 4 quarters average of 0.6
DRIO's equity is down by 14% since the previous quarter and by 14% year-on-year
DRIO's P/S is 81% below its 5-year quarterly average of 7.7 and 39% below its last 4 quarters average of 2.4
The revenue rose by 20% since the previous quarter but it has declined by 2.1% year-on-year
Efficiency
How efficient is DarioHealth business performance
DRIO's ROA is up by 30% YoY and by 6% QoQ
DRIO's ROS is up by 22% since the previous quarter and by 13% year-on-year
DarioHealth's return on equity has increased by 18% YoY
The ROIC has grown by 12% YoY
Dividends
What is DRIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DRIO.
Financial health
How did DarioHealth financials performed over time
The total assets is 114% greater than the total liabilities
The quick ratio has shrunk by 79% YoY and by 33% QoQ
DarioHealth's current ratio has plunged by 77% YoY and by 31% from the previous quarter
The debt is 48% less than the equity
The company's debt to equity rose by 18% YoY and by 16% QoQ
DRIO's equity is down by 14% since the previous quarter and by 14% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.